Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy

NCT03418324 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: TRC105
DRUG: Abiraterone
DRUG: Enzalutamide

Sponsor

Cedars-Sinai Medical Center